Skip to content

Our press coverage following our Novartis collaboration

| Media coverage

Take a look at the links below to see Artios’ press coverage following our Novartis collaboration.

Endpoints  

Novartis taps DNA damage specialist Artios in $1.3B discovery deal to complement growing radioligand portfolio

BioWorld  

Artios, Novartis combining DDR approach with radioligands in three-year, $1.3B deal

BioCentury  

Artios adds to financial runway via radioligand target deal with Novartis

GEN  

Novartis, Artios Pharma Target Cancer in Up-to-$1.3B DDR Collaboration

 

Fierce Biotech          

 

 

Novartis taps Artios for targets to enhance radioligand drugs

Pharmaphorum  

Novartis expands in radio-oncology again with $1.3bn Artios alliance

The Pharma Letter  

Artios links up with Novartis on DDR cancer therapies

Pharma Times  

Artios, Novartis form cancer therapies collaboration

Pharmafile  

Novartis and Artios Pharma to collaborate on DDR cancer therapies

PharmaShots  

Novartis Collaborates with Artios Pharma to Discover Next Generation DDR Cancer Therapies

Benzinga  

Novartis Taps Artios In Discovery Pact To Enhance Radioligand Portfolio

Awp  

Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus

L’Agefi  

Novartis s’assure les services d’Artios pour se développer en oncologie

Cash.ch  

Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus

Finanzen.ch  

Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus – Aktie dennoch rot

Bilan  

Novartis s’assure les services d’Artios pour se développer en oncologie

Marketscreener  

Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus

Investfeed  

Novartis expands oncology pipeline through collaboration with Artios Pharma

Tradedirect  

Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus

VOX Markets  

Arix’s Artios Pharma enters global research collaboration with Novartis

Biospace  

Artios, Novartis Aim to Develop and Discover DDR Targets for Cancer in New Partnership

 

Republic of Innovation

 

 

Oncologie : Novartis va collaborer avec Artios Pharma